# Plain Language Summary: Protecting Reproductive Freedom Act

This bill would prevent states from restricting access to two medications used for medical abortion: mifepristone and misoprostol. Specifically, it would stop states from banning the shipment of these drugs across state lines, requiring them to be given in person by a doctor, or prohibiting their prescription through telehealth (video consultations with doctors). In practical terms, if this bill became law, someone in a state with strict abortion laws could potentially receive these medications by mail from another state or through a remote doctor's appointment, and their home state couldn't legally block that.

The bill essentially overrides state-level restrictions by establishing a federal floor—meaning federal law would take priority over stricter state laws on this specific issue. This is significant because many states have passed laws limiting access to medication abortion, and this bill would make those restrictions unenforceable. The medications themselves are already approved by the FDA for medical abortion, so the bill isn't changing what drugs are legal nationally; it's changing how and where people can access them.

The bill also requires the Department of Health and Human Services to submit a report within 30 days outlining ways to further expand access to abortion medication. This suggests the legislation is part of a broader effort to make these medications more widely available across the country, regardless of individual state policies.

Protecting Reproductive Freedom Act

Ryan, Patrick

Protecting Reproductive Freedom Act This bill prohibits states from restricting mifepristone or misoprostol that is approved for medical abortion from being sent across state lines or from being prescribed by telehealth. States are also prohibited from establishing in-person dispensing requirements.